Trendlines Group Co-Chairman Steve Rhodes taking Singapore analysts and investors on a tour of his company's premises in Israel. NextInsight file photo.TRENDLINES GROUP's workings -- which Singapore investors are not entirely familiar with -- can be understood better through two events that took place last month (March 2016).
These were announced by Trendlines on 1 April.
| ♦ Magdent Ltd attracts US$800K in investment | ||
|
Magdent Ltd is one of the 47 start-ups being incubated by Trendlines in Israel.
Magdent focuses on developing a specialized cap for dental implants that utilizes an electromagnetic field to stimulate and improve bone formation surrounding the implant. |
| ♦ LapSpace Medical receives CE Mark for its inflatable retractor | ||
The product has received the CE Mark, which opens the way for it to be sold in Europe. Earlier, it had received FDA clearance for sale in the US. The device has been used successfully in more than 50 surgeries and a clinical trial at Johns Hopkins Hospital. During the procedures, it was discovered that the device is suitable for additional applications which increase the potential market, with over 8 million laparoscopic procedures carried out a year. Founded in 2011, LapSpace has gone from pure idea to product prototype to clinical trials. The achievement of CE mark and FDA approval are, needless to say, vital milestones that increase its value. At some point, Trendlines would exit the start-up with a multi-fold return on its investment . The latter, by the way, amounts to US$115,000 in cash and about US$450,000 in services rendered as an incuabtor over two years. And the Israeli government, which provided US$652,000 in grants, will get its money back. Watch this video on LapSpace's product --> |
